Sleep Apnea Doesn't Look the Same in Women. And That's Why It Gets Missed.

Sleep Apnea in Women: The Symptoms That Are Different, the Diagnoses That Are Wrong, and What to Do About It

By John Corbett | Psychologist | Hong Kong

There is a version of sleep apnea that most people recognise.

The overweight middle-aged man who snores loudly. Who stops breathing in ways his partner notices. Who wakes gasping. Who is demonstrably, obviously exhausted during the day. Whose condition, when it is eventually investigated, turns out to be exactly what it looked like from the outside.

That version exists. It is also, it turns out, only part of the picture.

Because sleep apnea in women frequently looks nothing like that. It presents differently, is described differently, and is — as a direct consequence — diagnosed later, if at all.

Up to 75% of women with obstructive sleep apnea remain undiagnosed. Not because the condition is not present. Because it does not look, at first assessment, like what most clinicians — and most patients — expect sleep apnea to look like.

This article is an attempt to change that, for the women reading it and for the people around them.

Why Sleep Apnea Has Been Understood as a Male Condition

The history of sleep apnea research is predominantly male. Early clinical studies on obstructive sleep apnea were conducted almost exclusively on male populations — reflecting a broader pattern in medical research in which men were used as the default research subject, and the findings were assumed to generalise to women.

The clinical tools developed for screening sleep apnea — the questionnaires, the risk criteria, the referral pathways — were built around the male presentation. Loud snoring. Witnessed apneas. Excessive daytime sleepiness. Neck circumference. Body weight. These criteria identify sleep apnea effectively in men. They are significantly less effective at identifying it in women, whose presentation is systematically different.

The consequence is a diagnostic gap that has persisted for decades. Research consistently shows that women with sleep apnea are less likely to be referred for sleep studies, less likely to be investigated, and when investigated, less likely to be diagnosed — not because the condition is absent but because the presentation does not fit the template through which it is being assessed.

Women with obstructive sleep apnea face longer diagnostic delays than men. They have a 28% higher mortality risk compared to women without the condition. The diagnostic gap has measurable health consequences. And yet the gap persists.

How Sleep Apnea Presents Differently in Women

This is the clinical heart of the article — and the most important section for any woman who has been sleeping poorly, has been told she is stressed or anxious or depressed, and has never had her sleep properly evaluated.

Women with sleep apnea report a different constellation of symptoms from the classic male presentation. They are less likely to report loud snoring as a primary complaint. They are less likely to have witnessed apneas — partly because women are less likely to have a bed partner who notices and reports breathing pauses, and partly because the breathing disruptions in women tend to be subtler — involving partial airway collapse and hypopneas rather than the dramatic complete apneas more common in men.

What women with sleep apnea more commonly report is:

Fatigue rather than sleepiness. The distinction matters. Excessive daytime sleepiness — the overwhelming urge to sleep at inappropriate times — is the symptom most associated with sleep apnea in clinical awareness. Women with sleep apnea are more likely to present with fatigue — a persistent, heavy tiredness that does not resolve with rest. This symptom is more easily attributed to other causes: overwork, stress, anaemia, thyroid dysfunction, the demands of family life. The attribution is understandable. It is also frequently wrong.

Insomnia. Women with sleep apnea disproportionately report difficulty falling asleep and maintaining sleep — the symptoms of insomnia. When the fragmented sleep produced by sleep apnea is experienced primarily as difficulty sleeping rather than as daytime sleepiness, the diagnosis points toward a sleep-initiation problem rather than a breathing disorder. The underlying cause goes uninvestigated.

Mood disturbances. Depression, anxiety, irritability, mood swings — these are significantly more common presenting symptoms in women with sleep apnea than in men. They are also significantly more likely to be treated as primary conditions rather than as symptoms of an underlying sleep disorder. The woman who presents to her GP with low mood and fatigue is far more likely to leave with an antidepressant prescription than a referral for a sleep study — even when a sleep disorder is driving both symptoms.

Morning headaches. A symptom reported more commonly by women than men with sleep apnea, and one frequently attributed to tension, dehydration, or hormonal factors.

Cognitive complaints. Difficulty concentrating, memory problems, mental fog — reported at high rates by women with sleep apnea, and similarly attributed to stress, hormonal changes, or the early stages of other conditions.

The clinical consequence of this symptom profile is systematic misdiagnosis. Women with sleep apnea are more likely than men to receive diagnoses of depression, anxiety, anaemia, hypothyroidism, chronic fatigue, or simply stress — while the sleep disorder producing or contributing to all of these symptoms goes undetected.

The Hormonal Dimension

Sleep apnea risk in women is significantly influenced by hormonal status — a dimension that has no direct parallel in male presentation and that is important for understanding when sleep apnea risk is elevated across a woman's life.

Menopause. Post-menopausal women are more than three times as likely to have sleep apnea as pre-menopausal women. The protective effect of progesterone — which maintains upper airway muscle tone and influences the respiratory control systems — is lost after menopause. The redistribution of body fat that accompanies menopause, including increased fat deposits around the upper airway, further elevates risk. Sleep apnea in post-menopausal women is dramatically underdiagnosed, partly because the symptoms — disturbed sleep, mood changes, cognitive difficulties, fatigue — overlap so completely with the expected symptoms of menopause itself.

The woman who attributes her post-menopausal sleep difficulties to hormonal change is not making an unreasonable assumption. She may also be missing a treatable condition that is running alongside or driving those difficulties.

Pregnancy. Physiological changes during pregnancy — weight gain, fluid retention, hormonal shifts, and changes in the position and mobility of the upper airway — significantly increase the risk of developing sleep apnea during gestation. Untreated sleep apnea during pregnancy is associated with elevated blood pressure, gestational diabetes, pre-eclampsia, and adverse foetal outcomes. Screening for sleep apnea during pregnancy is not yet standard practice — and yet the condition is both common and consequential in this population.

Polycystic ovary syndrome. PCOS is associated with significantly elevated rates of sleep apnea — estimated at 17 to 70 times the rate of the general female population in some studies. The mechanisms include the hyperandrogenaemia associated with PCOS, which reduces upper airway protective effects, and the metabolic profile — including insulin resistance and weight gain — that elevates anatomical risk.

Women with PCOS who report sleep difficulties should be specifically evaluated for sleep apnea. Most currently are not.

Why Clinicians Miss It

The diagnostic gap in sleep apnea for women is not solely about symptom presentation. It is also about the clinical context in which those symptoms are assessed.

The clinical gestalt — the intuitive pattern recognition that experienced clinicians rely on — for sleep apnea is male. Overweight. Loud snorer. Middle-aged. The woman who does not fit this picture is less likely to have sleep apnea suggested as a possibility, regardless of the symptoms she presents.

Standard sleep apnea screening questionnaires — the STOP-BANG questionnaire most commonly used in clinical settings — were validated primarily on male populations and systematically underperform for women, producing false negatives that delay referral.

Even when women are referred for sleep studies, the standard diagnostic thresholds — the Apnea-Hypopnea Index cutoffs that define mild, moderate, and severe sleep apnea — may be less appropriate for women, whose oxygen desaturation patterns and arousal thresholds differ from men. Women tend to have less dramatic oxygen drops during sleep than men with equivalent severity — potentially allowing the condition to fall below the diagnostic threshold even when it is producing significant clinical consequences.

The result is a compounding of errors. Symptoms that differ from the expected pattern. Screening tools that underperform. Diagnostic thresholds that may not apply. And a clinical bias that makes the diagnosis less likely to be considered in the first place.

The Mental Health Consequences of Missed Sleep Apnea in Women

This is the dimension of the issue most directly relevant to the work I do — and the one most likely to be affecting women who are presenting with psychological symptoms that are not resolving as expected.

The bidirectional relationship between sleep apnea and mental health is well-established. Sleep apnea causes or exacerbates depression and anxiety through several mechanisms: sleep fragmentation that disrupts the emotional processing occurring during REM sleep, intermittent hypoxia that affects mood-regulating neurotransmitter systems, and the chronic fatigue that narrows emotional range and reduces resilience.

In women, this relationship is particularly significant — partly because women present with mood symptoms at higher rates than men, and partly because the mood symptoms of sleep apnea in women are more likely to be treated as the primary diagnosis rather than as a signal pointing toward an underlying sleep disorder.

The woman who has been on antidepressant medication for two years, whose mood has partially improved but never fully resolved, who continues to sleep poorly and wake exhausted, who cannot understand why the treatment that should be working is not fully working — the possibility that an undiagnosed sleep disorder is maintaining the mood symptoms she is being treated for should be part of the clinical picture.

It frequently is not.

The treatment of depression and anxiety in women with undiagnosed sleep apnea will always be partial at best. The psychological intervention — however appropriate and well-delivered — is working against a physiological condition that is continuing to disrupt the sleep architecture on which emotional regulation depends. Addressing the sleep disorder does not replace the psychological treatment. But it may be a prerequisite for the psychological treatment to work as well as it should.

What to Do With This Information

If you are a woman who has recognised herself in what's been described — the fatigue that rest doesn't touch, the mood that treatment hasn't fully resolved, the sleep that looks adequate in hours but doesn't feel restorative, the headaches and the brain fog and the inexplicable persistent tiredness — the most useful next step is to raise the possibility of sleep apnea with a doctor who takes it seriously.

This involves being specific about what you are experiencing. Not just "I'm tired" — the specific quality of the tiredness. How it feels in the morning. Whether sleep feels restorative. Whether you wake with headaches. Whether your partner has noticed anything about your breathing during sleep (or whether you sleep alone, which removes that information source entirely).

It involves asking specifically for a sleep apnea evaluation — not accepting the first attribution to stress or hormones or depression without ruling out a sleep disorder that presents with all of those symptoms.

And it involves knowing that home sleep studies — which can be conducted with a portable device in your own bedroom — are widely available and are a practical, accessible first step toward finding out whether sleep apnea is part of the picture.

The diagnostic gap exists. But it is not inevitable. It closes when the people experiencing the symptoms have the information to advocate for the right evaluation.